(RTTNews) - The Australian market is trimming the early gains in mid-market moves on Thursday, extending the gains in the previous session, following the broadly positive cues from Wall Street overnight. The benchmark S&P/ASX 200 is moving above the 8,850 level, with gains in min
(RTTNews) - The Australian market is trimming the early gains in mid-market moves on Thursday, extending the gains in the previous session, following the broadly positive cues from Wall Street overnight. The benchmark S&P/ASX 200 is moving above the 8,850 level, with gains in min
Earnings Call Insights: Mirum Pharmaceuticals (MIRM) Q1 2026 Management view "Based on that demand and continued performance across all brands, we are raising our full year revenue guidance to $660 million to $680 million." (CEO & Director Christopher Peetz) "In PSC, the VISTAS study of volixibat showed a significant improvement in pruritus... and positions volixibat as a potential first approved ...
Earnings Call Insights: Mirum Pharmaceuticals (MIRM) Q1 2026 Management view "Based on that demand and continued performance across all brands, we are raising our full year revenue guidance to $660 million to $680 million." (CEO & Director Christopher Peetz) "In PSC, the VISTAS study of volixibat showed a significant improvement in pruritus... and positions volixibat as a potential first approved medicine for patients in the U.S." (CEO & Director Peetz) "In hepatitis delta, results from the Phase IIb portion of the AZURE 1 study further support the potential for brelovitug... We look forward to the upcoming late-breaking presentations for both VISTAS and AZURE at EASL later this month." (CEO & Director Peetz) "Today, we are announcing another step... with the addition of zilurgisertib recently licensed from Incyte... an NDA has been accepted for priority review with a PDUFA date of September 26 this year. If approved, we expect to launch by year-end." (CEO & Director Peetz) "The first quarter was another period of strong commercial execution with total net product sales of approximately $160 million." (COO & President Peter Radovich) "This included LIVMARLI net product sales of $84 million in the U.S. and $30 million internationally, with the bile acid medicines contributing $46 million." (COO & President Radovich) "After our planned expansion to approximately 60 U.S. field commercial personnel, we anticipate being able to reach over 4,000 liver health care professionals." (COO & President Radovich) "We are excited about the addition of zilurgisertib... and reach peak sales of over $200 million." (COO & President Radovich) "Cash, cash equivalents and investments as of March 31 were $421 million." (Chief Financial Officer Eric Bjerkholt) Outlook "We are raising our full year revenue guidance to $660 million to $680 million." (CEO & Director Peetz) "We plan to expand our U.S. and international teams starting later this year" to support potential adult-liver launches, ...
Earnings Call Insights: Aurora Innovation (AUR) Q1 2026 Management View "2026 is the year Aurora begins to scale." (Co-Founder, CEO & Non-Independent Executive Chairman Christopher Urmson) "This program positions us to exit the year with over 200 driverless trucks in operation across the Sunbelt and supports our broader scaling ambitions in 2027 and beyond." (CEO Urmson) "In addition to the Transp...
Earnings Call Insights: Aurora Innovation (AUR) Q1 2026 Management View "2026 is the year Aurora begins to scale." (Co-Founder, CEO & Non-Independent Executive Chairman Christopher Urmson) "This program positions us to exit the year with over 200 driverless trucks in operation across the Sunbelt and supports our broader scaling ambitions in 2027 and beyond." (CEO Urmson) "In addition to the Transportation as a Service commitments we already have in place with Hirschbach we announced last week that they have selected Aurora to scale their autonomous fleet with intent to own and operate 500 trucks through our Driver-as-a-Service business model." (CEO Urmson) "We expect to finalize the definitive agreement, which represents a potential multiyear revenue stream in the hundreds of millions of dollars later this year with truck delivery slated to begin in 2027." (CEO Urmson) "California has reached a watershed moment, joining the vast majority of states in enabling autonomous trucking." (CEO Urmson) "In April, the Aurora Driver surpassed 370,000 driverless miles with 100% on-time performance and 0 Aurora Driver attributed collisions." (CEO Urmson) "We expect this kit to drive a 50-plus percent reduction in Aurora Driver hardware costs, a key lever supporting our breakeven gross margin target." (CEO Urmson) "First quarter 2026 revenue totaled $1 million across driverless and vehicle operator supervised commercial loads." (Chief Financial Officer David Maday) "We ended the quarter with a very strong balance sheet, including liquidity of nearly $1.3 billion in cash and short-term and long-term investments." (CFO Maday) Outlook "We continue to expect 2026 revenue of $14 million to $16 million up 400% year-over-year at the midpoint." (CFO Maday) "Revenue will be back-end loaded with the fourth quarter projected to contribute over half of full year revenue." (CFO Maday) "We anticipate exiting the year with more than 200 driverless trucks in operation." (CFO Maday) "We expect th...
(RTTNews) - Asian markets are a sea of green on Thursday, following the broadly positive cues from Wall Street overnight, with the Japanese markets surging in post-holiday trading, amid optimism over a potential U.S.-Iran peace deal and the related easing of crude oil prices and
(RTTNews) - Asian markets are a sea of green on Thursday, following the broadly positive cues from Wall Street overnight, with the Japanese markets surging in post-holiday trading, amid optimism over a potential U.S.-Iran peace deal and the related easing of crude oil prices and